AGP Executive Report
Last update: 9 hours agoMedicare 2027: CMS finalized physician payment cuts of 1.83% to 2.31%, while outpatient hospital rates rise 2.3% and home health payments 2.4%. The rules also expand site-neutral imaging payments and tighten provider enrollment oversight. Drug Costs: Average premiums for stand-alone Medicare Part D plans are projected to jump 50%, to $51 a month in 2027, for members who stay in the same plan. Healthcare Shake-up: CVS plans to separate its nearly 9,000 retail pharmacies into a new public company in 2028, leaving Aetna, Caremark and specialty operations together. Obesity Treatments: AstraZeneca has reportedly offered about $10 billion for rare-disease drugmaker Rhythm Pharmaceuticals. Novo Nordisk’s oral Wegovy brought in $811 million in third-quarter sales, beating forecasts and helping lift the company’s outlook. Washington: Democrats’ midterm victories set up a push to reverse Medicaid cuts, extend ACA subsidies and scrutinize healthcare costs, though President Trump could veto legislation.
Note: AI summary from news headlines; neutral sources weighted more to help reduce bias in the result. Feedback is welcome. Please let us know if you have any comments or suggestions about the AGP Executive Report.
Perspectify News
